beta-Hydroxybutyrate inhibits myocardial fatty acid oxidation in vivo independent of changes in malonyl-CoA content.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  2003-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1152/AJPHEART.00332.2003PMID 12969881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ketone bodies disturb fatty acid handling in isolated cardiomyocytes derived from control and diabetic rats.

  2003cited by this paper
• Effect of hyperglycemia and fatty acid oxidation inhibition during aerobic conditions and demand-induced ischemia.

  2003cited by this paper
• Increased nonoxidative glycolysis despite continued fatty acid uptake during demand-induced myocardial ischemia.

  2002cited by this paper
• Malonyl CoA control of fatty acid oxidation in the ischemic heart.

  2002cited by this paper
• Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs.

  2002cited by this paper
• Malonyl-CoA metabolism in cardiac myocytes.

  2000cited by this paper
• Regulation of fatty acid oxidation of the heart by MCD and ACC during contractile stimulation.

  1999cited by this paper
• Free fatty acid kinetics and oxidation in congestive heart failure.

  1998cited by this paper
• Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions.

  1997cited by this paper
• Malonyl-CoA regulation in skeletal muscle: its link to cell citrate and the glucose-fatty acid cycle.

  1997cited by this paper
• Decreased myocardial glucose uptake during ischemia in diabetic swine.

  1997cited by this paper
• Heart failure ketosis

  1997cited by this paper
• Blood ketone bodies in congestive heart failure.

  1996cited by this paper
• Increased cardiac fatty acid uptake with dobutamine infusion in swine is accompanied by a decrease in malonyl CoA levels.

  1996cited by this paper
• Pyruvate dehydrogenase activity and malonyl CoA levels in normal and ischemic swine myocardium: effects of dichloroacetate.

  1996cited by this paper
• Impaired pyruvate oxidation but normal glucose uptake in diabetic pig heart during dobutamine-induced work.

  1996cited by this paper
• High Rates of Fatty Acid Oxidation during Reperfusion of Ischemic Hearts Are Associated with a Decrease in Malonyl-CoA Levels Due to an Increase in 5′-AMP-activated Protein Kinase Inhibition of Acetyl-CoA Carboxylase (*)

  1995cited by this paper
• beta-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of continued progress.

  1995cited by this paper
• Regulation of fatty acid oxidation in the mammalian heart in health and disease.

  1994cited by this paper
• Energy metabolism of the heart: from basic concepts to clinical applications.

  1994cited by this paper
• Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart.

  1993cited by this paper
• Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation.

  1993cited by this paper
• Competition between palmitate and ketone bodies as fuels for the heart: study with positron emission tomography.

  1993cited by this paper
• Effects of diabetes and insulin on ketone bodies metabolism in heart

  1992cited by this paper
• The Heart: Physiology and Metabolism

  1991cited by this paper
• Resting energy expenditure in chronic cardiac failure.

  1991cited by this paper
• Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease.

  1990cited by this paper
• Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans.

  1987cited by this paper
• Competition between fatty acids and carbohydrate or ketone bodies as metabolic fuels for the isolated perfused heart.

  1987cited by this paper
• Quantitation of the efflux of acylcarnitines from rat heart, brain, and liver mitochondria.

  1986cited by this paper
• Fuel selection in animals.

  1986cited by this paper
• Inhibitory effects of the D(-)isomer of 3-hydroxybutyrate on cardiac non-esterified fatty acid uptake and oxygen demand induced by norepinephrine in the intact dog.

  1985cited by this paper
• Regulation of Substrate Oxidation in Isolated Myocardial Cells by β-Hydroxybutyrate

  1984cited by this paper
• Effect of ketones on metabolism of FFA by dog myocardium and skeletal muscle in vivo.

  1970cited by this paper
• Concentrations of glycerides and phospholipids in rat heart and gastrocnemius muscles. Effects of alloxan-diabetes and perfusion.

  1967cited by this paper
• Regulation of glucose uptake by muscle. 7. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes, starvation, hypophysectomy and adrenalectomy, on the concentrations of hexose phosphates, nucleotides and inorganic phosphate in perfused rat heart.

  1964cited by this paper
• Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles.

  1964cited by this paper
• Regulation of Glucose Uptake by Muscle

  1962cited by this paper

• Defects in auxiliary fuel oxidation and mitochondrial pyruvate transport mark transition to overt heart failure in Tgαq*44 mice.

  2026cites this paper
• The multifaceted roles of ketones in physiology

  2025cites this paper
• Characteristics of Cardiac Ketone Body Metabolism Throughout the Life Cycle

  2025cites this paper
• Cardiac substrate metabolism in type 2 diabetes

  2025cites this paper
• Underlying mechanisms of ketotherapy in heart failure: current evidence for clinical implementations

  2024cites this paper
• The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists in the Management of Obesity-Related Heart Failure with Preserved Ejection Fraction: Benefits beyond What Scales Can Measure?

  2024cites this paper
• Effect of Hyperketonemia on Myocardial Function in Patients With Heart Failure and Type 2 Diabetes

  2024cites this paper
• Cardiac fibrogenesis: an immuno-metabolic perspective

  2024cites this paper
• Tackling metabolic defects in HFpEF.

  2024cites this paper
• SGLT2 inhibition alters substrate utilization and mitochondrial redox in healthy and failing rat hearts

  2024cites this paper
• Stimulation of the Hydroxycarboxylic Acid Receptor 2 With the Ketone Body 3‐Hydroxybutyrate and Niacin in Patients With Chronic Heart Failure: Hemodynamic and Metabolic Effects

  2023cites this paper
• Myocardial Metabolism in Heart Failure

  2023cites this paper
• A 15 Year Evolution of Dichloroacetate-Based Metabolic Cancer Therapy: A Review with Case Reports

  2023cites this paper
• Ketones and the Heart: Metabolic Principles and Therapeutic Implications

  2023cites this paper
• Cardiac Metabolism, Reprogramming, and Diseases

  2023cites this paper
• Metabolic Changes Associated With Cardiomyocyte Dedifferentiation Enable Adult Mammalian Cardiac Regeneration

  2022cites this paper
• FULMINANT MYOCARDITIS-A UNIQUE COMPLICATION OF COVID-19

  2021cites this paper
• Energy metabolism homeostasis in cardiovascular diseases

  2021cites this paper
• Ketone Body Metabolism in the Ischemic Heart

  2021cites this paper
• CARDIOKIN1: Computational Assessment of Myocardial Metabolic Capability in Healthy Controls and Patients With Valve Diseases

  2021cites this paper
• Metabolic Complications in Cardiac Aging

  2021cites this paper
• Ketone Therapy for Heart Failure: Current Evidence for Clinical Use.

  2021cites this paper
• CrossTalk opposing view: Ketone bodies are not an important metabolic fuel for the heart

  2021cites this paper
• CrossTalk proposal: Ketone bodies are an important metabolic fuel for the heart

  2021cites this paper
• Fatty acid oxidation participates of the survival to starvation, cell cycle progression and differentiation in the insect stages of Trypanosoma cruzi

  2021cites this paper
• Tissue specificity of energy metabolism in mitochondria

  2021cites this paper
• Ketogenic Diet Prevents Heart Failure from Defective Mitochondrial Pyruvate Metabolism

  2020cites this paper
• Nutritional modulation of heart failure in mitochondrial pyruvate carrier–deficient mice

  2020cites this paper
• Omega-3 fatty acid prevents the development of heart failure by changing fatty acid composition in the heart

  2020cites this paper
• Increased Glucose Availability Attenuates Myocardial Ketone Body Utilization

  2020cites this paper
• Ketones can become the major fuel source for the heart but do not increase cardiac efficiency.

  2020cites this paper
• Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure

  2020cites this paper
• Bariatric Surgery Rapidly Decreases Cardiac Dietary Fatty Acid Partitioning and Hepatic Insulin Resistance Through Increased Intra-abdominal Adipose Tissue Storage and Reduced Spillover in Type 2 Diabetes

  2020cites this paper
• Cardiac ketone body metabolism.

  2020cites this paper
• Ketone body metabolism in failing heart.

  2020cites this paper
• Energy metabolism disorders and potential therapeutic drugs in heart failure

  2020cites this paper
• Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency.

  2019cites this paper
• Novel Concepts in Cardiac Energy Metabolism: From Biology to Disease

  2019cites this paper
• Fatty Acid Uptake by the Heart During Fasting

  2019cites this paper
• Myocardial Metabolism

  2019cites this paper
• Molecular Mechanisms Responsible for Diastolic Dysfunction in Diabetes Mellitus Patients

  2019cites this paper
• How Hypertension Affects Heart Metabolism

  2019cites this paper
• The impact of oral anti-diabetic medications on heart failure: lessons learned from preclinical studies

  2018cites this paper
• Empagliflozin reduces myocardial ketone utilization while preserving glucose utilization in diabetic hypertensive heart disease: A hyperpolarized 13C magnetic resonance spectroscopy study

  2018cites this paper
• Loss of Metabolic Flexibility in the Failing Heart

  2018cites this paper
• Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects

  2018cites this paper
• Consequences of Altered Short-Chain Carbon Metabolism in Heart Failure

  2017influential citation
• Ketone Body Infusion With 3‐Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study

  2017cites this paper
• Quantitative proteomic changes during post myocardial infarction remodeling reveals altered cardiac metabolism and Desmin aggregation in the infarct region.

  2017cites this paper
• The diabetic heart utilizes ketone bodies as an energy source.

  2017cites this paper
• Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics.

  2017cites this paper
• Probing early heart development to instruct stem cell differentiation strategies

  2016cites this paper
• Cardiomyocytes – Active Players in Cardiac Disease

  2016cites this paper
• CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis

  2016cites this paper
• Compound danshen dripping pills modulate the perturbed energy metabolism in a rat model of acute myocardial ischemia

  2016cites this paper
• Cardiac Metabolism and Energetic Control

  2016cites this paper
• The Failing Heart Relies on Ketone Bodies as a Fuel

  2016cites this paper
• Ketone Body Metabolism Preserves Hepatic Function during Adaptation to Birth and in Overnutrition

  2015cites this paper
• Substrate Metabolism in the Diabetic Heart

  2014cites this paper
• Using positron emission tomography to study human ketone body metabolism: a review.

  2014cites this paper
• Unique Metabolic Features of Stem Cells, Cardiomyocytes, and Their Progenitors

  2014cites this paper
• Glucose Uptake and Its Consequence on Cardiomyocyte Function

  2014cites this paper
• Role of β-hydroxybutyrate, its polymer poly-β-hydroxybutyrate and inorganic polyphosphate in mammalian health and disease

  2014cites this paper
• Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity

  2014cites this paper
• On Glucose Metabolism in Patients with the m.3243A>G Mutation

  2013cites this paper
• Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes.

  2013cites this paper
• Successful adaptation to ketosis by mice with tissue-specific deficiency of ketone body oxidation.

  2013cites this paper
• Ketone body metabolism and cardiovascular disease.

  2013cites this paper
• Alterations of fatty acid β-oxidation capability in the liver of ketotic cows.

  2012cites this paper
• Metabolism, hypoxia and the diabetic heart.

  2011cites this paper
• La diabetes mellitus y la cardioprotección

  2011cites this paper
• The fascinating and elusive life of cardiac fatty acids.

  2011cites this paper
• The fascinating and elusive life of cardiac fatty acids

  2011cites this paper
• Adaptation of Myocardial Substrate Metabolism to a Ketogenic Nutrient Environment*

  2010cites this paper
• Myocardial fatty acid metabolism in health and disease.

  2010cites this paper
• Type 2 diabetes, mitochondrial biology and the heart.

  2009cites this paper
• The effect of glucose on cardiac AMP-activated protein kinase

  2009cites this paper
• Oxidation of Intracellular and Extracellular Fatty Acids in Skeletal Muscle: Application of kinetic modeling, stable isotopes and liquid chromatography/electrospray ionization ion-trap tandem mass spectrometry technology.

  2008cites this paper
• Regulation of myocardial substrate metabolism during increased energy expenditure: insights from computational studies.

  2006cites this paper
• Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia.

  2006cites this paper
• Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes.

  2006cites this paper
• Free fatty acids normalize a rosiglitazone-induced visfatin release.

  2006cites this paper
• Chronic activation of PPARα is detrimental to cardiac recovery after ischemia

  2006cites this paper
• Competition between acetate and oleate for the formation of malonyl-CoA and mitochondrial acetyl-CoA in the perfused rat heart.

  2006cites this paper
• Regulation of cardiac malonyl-CoA content and fatty acid oxidation during increased cardiac power.

  2005cites this paper
• Interrelation between long-chain fatty acid oxidation rate and carnitine palmitoyltransferase 1 activity with different isoforms in rat tissues.

  2005cites this paper
• Myocardial substrate metabolism in the normal and failing heart.

  2005cites this paper
• Cellular and physiological effects of short-chain fatty acids.

  2004cites this paper